Dr Ullas Batra

Medical Oncologist| Strive for cure in lung cancer| researcher| dreamer| bolllywood at heart| dreams and tweets are my own| RT not endorsements

[Dr Ullas Batra @ullas_batra]

@airindia fantastic ground service at t2 bangalore- akshaya!! way to go...

[Dr. Abhishek Shankar, MD, CPFP(NCI, USA), MBA @ShankarAbhishek]

Thank you @oncodaily for the coverage of our research publication.

https://t.co/uzOaftd6eB

@AIIMSDELHI57097, @MoHFW_INDIA, @ICMRDELHI @uicc @IGCSociety @IPVSociety

[Vinay Prasad MD MPH @VPrasadMDMPH]

Nature pays $0 for doing reviews and wants to give advice on how to avoid unpaid labor. Hahaha

[Pankaj Kumar Panda @pankajpanda86]

Very pertinent study from @amtdutt lab @VanitaNoronha @ACTREC_TMC @TataMemorial

Congratulations to the entire team!!

[Aakash Desai, MD, MPH, FASCO @ADesaiMD]

Join me today with @cancerGRACE @lungoncdoc @LeXiuning @triparnasen
and others for a GRACE virtual forum. We will be sharing insights on #lung cancer management strategies, including #EGFR #HER2, #KRAS #BRAF, and other #lcsm subtypes @ONealCancerUAB @uabmedicine

[Lung Connect India @LungConnectIN]

"There is a misconception that biopsy spreads cancer. However, the fact is Biopsy plays an important role in detection and staging of cancer."- Dr Ullas Batra

Watch here to know more- https://t.co/FM75pKFwY2

#lungconnectindiafoundation #lungconnect #CancerWarriorsUnite #healthcare #cancertreatment #cancersupportcommunity #lungcancer #lungcancerawareness #cancercare #biopsy #patientcare #mythbusters @ullas_batra @RGCI_RC

[Lung Connect India @LungConnectIN]

As a part of our #WorldCancerDay initiative "Lung Cancer Awareness: United in our goals", renowned oncologists Dr Kumar Prabhash, Dr Vanita Noronha and Dr Kunal Jobanputra have published an article on Lung Cancer Research and Development. We are thankful for their continued support.

Read here- https://t.co/TwjsEpPPNc

#UnitedByUnique @VanitaNoronha @KNJobanputra @Sanjeev_33 @oceanblue11oct @ndtv @ndtvindia @Cancer_Free_IND

[Lung Connect India @LungConnectIN]

Stay Tuned:

This #WorldCancerDay, Lung Connect India Foundation is proud to collaborate with NDTV—one of India’s leading news networks—to launch the campaign “Lung Cancer Awareness – United in Our Goals ".
Watch us live in the breakfast news in between 8am to 9am on NDTV 24X7 English from 3rd to 10th February.

3rd February- Dr Nitesh Rohatgi[ https://t.co/wd7FvSSBKS]
4th February- Sanjeev Sharma and Vandana Mahajan [https://t.co/upZDipiDvy]
6th February- Dr Kumar Prabhash
7th February- Aakansha Tripathi
9th February- Dr Ullas Batra
10th February- Mohammad Rizwan

@ndtv @ndtvindia @NiteshRohatgi @fortis_mhbs @Sanjeev_33 @oceanblue11oct @ullas_batra @Md_Rizwan6835

#worldcancerdayatlcif #lungconnect #UnitedbyUnique #cancertreatment #cancersupportcommunity #cancerawareness #lungcancer #LungCancerAwareness

[Dr Amol Akhade @SuyogCancer]

Some of the " funny " slides from my talk today about importance of phase 3 RCT for drugs approvals in oncology 😀 @brunolarvol @MrPug94 @5_utr @BalazsHalmosMD

[Urvashi Prasad @urvashi01]

.@Pfizer This is a BEYOND EXORBITANT cost for at least 95% of India’s population, if not more! I am myself on Lorlatinib and I KNOW the struggle.

I understand the need to make profits, but should it be at the cost of lives?! Please DO BETTER. @PMOIndia @narendramodi @MoHFW_INDIA @AyushmanNHA

[Amol Patel @Amolpatel_dr]

Financial Toxicity is a grade 6 toxicity.
Borrowed money, debt, out of pocket expenses... After death also, it haunts.
Grades of cancer treatment toxicities are 1 to 5. (From mild to death).
Request EORTC to include this in toxicity criteria.

[ALK Positive India @IndiaAlk]

.@pfizer Lorlatinib costs ₹250,000 for 30 tablets in India. Even with patient assistance, ₹125,000/month is beyond reach for most ALK+ patients, & they are dying. Please make Lorlatinib, the only 3rd-gen ALK med, affordable in India—like Crizotinib
@CDSCO_INDIA_INF @PMOIndia

[Vivek Tomar #RiseToSurviveCancer @R2SurviveCancer]

This is a clear example of the issues of #FinancialToxicity, #Access, #Affordability, and #Equity faced by cancer patients in India!

@Amolpatel_dr @ullas_batra @Prabhatmalikmd @VanitaNoronha @SewantiLimaye @ns_chd @DrBivas @docrohatgi @oncologician @DrVijayPatil11

[Vanita Noronha, MBBS MD DM @VanitaNoronha]

For locally advanced #EsophagealCancer, pacli+ platiunum is non-inferior to 5FU-platinum, with less S/Es and higher pCR of 26% #esocsm #GICSM https://t.co/pOEyRLsikm @oncoalert @DrVijayPatil11 @TataMemorial @tmhmedoncalumni @Nandinimenon18 @montypal @neerajaiims @drakhilkapoor1

[Dr Riyaz Shah @DrRiyazShah]

Can inhaled corticosteroid reduce RT induced lung damage during radical lung rt for unresectable IIIa/b?; n292; yes it can. 15% reduction in radiation pneumonitis. #ESMO24 lovely trial; practice changing #ESMO24

[Maxi Hristov @Maxi_Heights]

6 Rules That Made Me Unstoppable 🧵

1.

[Chinmay Jani @Jani_Chinmay]

Had a great discussion with @ullas_batra from #India and @RamilaShilpakar @medicoshama from #Nepal! We need a future collaboration to better understand #Cancer outcomes in the #SouthAsian population. A true hope to create a #GlobalOncology project! @GlopesMd
@ADesaiMD @SarjuGanatraMD @RamalingamMD @lungoncdoc @CharuAggarwalMD @neerajaiims @VamsiVelcheti @vsanchorawala @OncBrothers

[Naveen Sankar S @NaveenSankarS]

Humans are absorbing microplastics at an unprecedented rate which is increasing the risk of #cancer ☹️
#health #news

[Sabita Jiwnani @drsabita]

Wonderful to listen to stories of #DEI champions from across the world
🔅Embrace work-life integration rather than struggling to achieve a work-life balance!
⛔️ Maintain consistent boundaries
📣 Make sure you’re heard
🛠️ Fight discrimination
🔛 Equity for all
#WCLC2024

[Dr Ullas Batra @ullas_batra]

@aparna96 @IASLC @lcfamerica many congrats and hope many more accolades come ur way!!